Can Ebola virus become endemic in the human population?

References

[1] Baxter AG (2000) Symptomless infection with Ebola virus. Lancet 355:2178–2179

[2] Becquart P, Wauquier N, Mahlakoiv T, Nkoghe D, Padilla C, Souris M, Ollomo B, Gonzalez JP, De Lamballerie X, Kazanji M et al(2010) High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One 5:e9126

[3] CDC.gov (2014) Outbreaks chronology: Ebola virus disease. http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html

[4] CDC.gov (2015) Possible sexual transmission of Ebola virus—liberia.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm64e0501a1.htm?s_cid=mm64e0501a1_x

[5] Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ(1999) Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179(Suppl 1):S87–S91

[6] Feldmann H, Sanchez A, Geisbert TW (2013) Filoviridae: Marburg and Ebola viruses. Lippincott Williams and Wilkins, Philadelphia

[7] Hoenen T, Safronetz D, Groseth A, Wollenberg KR, Koita OA, Diarra B, Fall IS, Haidara FC, Diallo F, Sanogo M et al (2015) Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science 348:117–119

[8] Jenkins GM, Rambaut A, Pybus OG, Holmes EC (2002) Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol 54:156–165

[9] NPR.org (2014) Endless Ebola epidemic? That’s the ‘risk we face now,’ CDC says. http://www.npr.org/blogs/goatsandsoda/2014/12/15/370446566/endless-ebola-endemic-thats-the-risk-we-facenow-cdc-says

[10] Promedmail.org (2015) Ebola update (116): WHO, Scottish nurse relapse, suspected, research, funding. http://www.promedmail.org/direct.php?id=3708317

[11] Rodriguez LL, De Roo A, Guimard Y, Trappier SG, Sanchez A,Bressler D, Williams AJ, Rowe AK, Bertolli J, Khan AS et al(1999) Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 179(Suppl 1):S170–S176

[12] Rowe AK, Bertolli J, Khan AS, Mukunu R, Muyembe-Tamfum JJ,Bressler D, Williams AJ, Peters CJ, Rodriguez L, Feldmann H et al (1999) Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179(Suppl 1):S28–S35

[13] Tong YG, Shi WF, Liu D, Qian J, Liang L, Bo XC, Liu J, Ren HG, Fan H, Ni M et al (2015) Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone. Nature 524:93–96

[14] Varkey JB, Shantha JG, Crozier I, Kraft CS, Lyon GM, Mehta AK,Kumar G, Smith JR, Kainulainen MH, Whitmer S et al (2015)Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 372:2423–2427

[15] WHO Ebola Response Team (2014) Ebola virus disease in West Africa–the first 9 months of the epidemic and forward projections. N Engl J Med 371:1481–1495

[16] WHO.int (2014) WHO—frequently asked questions on Ebola virus disease.

[17] WHO.int (2015a) Ebola situation report—13 May 2015.

[18] WHO.int (2015b) Ebola transmission in Liberia over. Nation enters 90-day intensive surveillance period.

[19] Wong G, Liu W, Liu Y, Zhou B, Bi Y, Gao GF (2015) MERS, SARS,and Ebola: the role of super-spreaders in infectious disease. Cell Host Microbe 18:398–401

RIGHTS & PERMISSIONS

The Author(s) 2015. This article is published with open access at Springerlink.com and journal.hep.com.cn